{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36716311", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "30"}], "Language": ["eng"], "ELocationID": ["e0274081", "10.1371/journal.pone.0274081"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "18", "Issue": "1", "PubDate": {"Year": "2023"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies.", "Pagination": {"StartPage": "e0274081", "MedlinePgn": "e0274081"}, "Abstract": {"AbstractText": ["Fifteen quinazoline derivatives were designed and synthesized as DNA intercalators. The cytotoxicity of the designed members was assessed against HCT-116 and HepG2 cancer cell lines. In addition, the topoisomerase II (Topo II) inhibitory effect was assessed. Compound 16 was the most cytotoxic and Topo II inhibitor with low cytotoxicity against Vero cells. Compounds 16, 17, and 18 showed significant DNA binding affinities. Compound 16 showed Topo II catalytic inhibitory effect at a concentration of 10 \u03bcM. Further mechanistic investigations revealed the capability of compound 16 to induce apoptosis in HCT-116 cells and arrest the growth at the S and G2/M phases. Also, compound 16 showed a significant increase in the level of BAX (2.18-fold) and a marked decrease in the level of Bcl-2 (1.9-fold) compared to the control cells. In silico studies revealed the ability of the synthesized members to bind to the DNA-Topo II complex."], "CopyrightInformation": "Copyright: \u00a9 2023 Gaber et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Gaber", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Sobhy", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Turky", "ForeName": "Abdallah", "Initials": "A"}, {"Identifier": ["0000-0001-6996-4017"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt."}], "LastName": "Eldehna", "ForeName": "Wagdy M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt."}], "LastName": "El-Sebaey", "ForeName": "Samiha A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Science, Higher Technological institute, 10th of Ramadan City, Egypt."}], "LastName": "El-Metwally", "ForeName": "Souad A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, Ain Shams University, Abassia, Cairo, Egypt."}], "LastName": "El-Naggar", "ForeName": "Abeer M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biophysics Department, Faculty of Science, Cairo University, Giza, Egypt."}], "LastName": "Ibrahim", "ForeName": "Ibrahim M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Topoisomerase II Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}, {"RegistryNumber": "EC 5.99.1.3", "NameOfSubstance": "DNA Topoisomerases, Type II"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Topoisomerase II Inhibitors"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinazolines"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA Topoisomerases, Type II"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nitiss J. L., Targeting DNA topoisomerase II in cancer chemotherapy. Nature Reviews Cancer 2009, 9 (5), 338\u2013350. doi: 10.1038/nrc2607", "ArticleIdList": ["10.1038/nrc2607", "PMC2748742", "19377506"]}, {"Citation": "Rescifina A., Zagni C., Varrica M. G., Pistar\u00e0 V., Corsaro A., Recent advances in small organic molecules as DNA intercalating agents: Synthesis, activity, and modeling. European journal of medicinal chemistry 2014, 74, 95\u2013115. doi: 10.1016/j.ejmech.2013.11.029", "ArticleIdList": ["10.1016/j.ejmech.2013.11.029", "24448420"]}, {"Citation": "Godzieba M., Ciesielski S., Natural DNA intercalators as promising therapeutics for cancer and Infectious diseases. Current cancer drug targets 2020, 20 (1), 19\u201332. doi: 10.2174/1568009619666191007112516", "ArticleIdList": ["10.2174/1568009619666191007112516", "31589125"]}, {"Citation": "Yokochi T., Robertson K. D., Doxorubicin inhibits DNMT1, resulting in conditional apoptosis. Molecular pharmacology 2004, 66 (6), 1415\u20131420. doi: 10.1124/mol.104.002634", "ArticleIdList": ["10.1124/mol.104.002634", "15340041"]}, {"Citation": "Ferguson L. R., Denny W. A., Genotoxicity of non-covalent interactions: DNA intercalators. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2007, 623 (1\u20132), 14\u201323. doi: 10.1016/j.mrfmmm.2007.03.014", "ArticleIdList": ["10.1016/j.mrfmmm.2007.03.014", "17498749"]}, {"Citation": "Graves D. E., Velea L. M., Intercalative binding of small molecules to nucleic acids. Current Organic Chemistry 2000, 4 (9), 915\u2013929."}, {"Citation": "Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L., Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological reviews 2004, 56 (2), 185\u2013229. doi: 10.1124/pr.56.2.6", "ArticleIdList": ["10.1124/pr.56.2.6", "15169927"]}, {"Citation": "Gallego J., Ortiz A. R., de Pascual-Teresa B., Gago F., Structure\u2013affinity relationships for the binding of actinomycin D to DNA. J. Comput. Aided Mol. Des. 1997, 11 (2), 114\u2013128. doi: 10.1023/a:1008018106064", "ArticleIdList": ["10.1023/a:1008018106064", "9089429"]}, {"Citation": "Bailey S. A., Graves D. E., Rill R., Binding of actinomycin D to the T (G) nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. Biochemistry 1994, 33 (38), 11493\u201311500. doi: 10.1021/bi00204a011", "ArticleIdList": ["10.1021/bi00204a011", "7918362"]}, {"Citation": "Tanious F. A., Yen S. F., Wilson W. D., Kinetic and equilibrium analysis of a threading intercalation mode: DNA sequence and ion effects. Biochemistry 1991, 30 (7), 1813\u20131819. doi: 10.1021/bi00221a013", "ArticleIdList": ["10.1021/bi00221a013", "1993195"]}, {"Citation": "Takagi M., Threading intercalation to double-stranded DNA and the application to DNA sensing. Electrochemical array technique. Pure and applied chemistry 2001, 73 (10), 1573\u20131577."}, {"Citation": "Boer D. R., Wu L., Lincoln P., Coll M., Thread Insertion of a Bis (dipyridophenazine) Diruthenium Complex into the DNA Double Helix by the Extrusion of AT Base Pairs and Cross\u2010Linking of DNA Duplexes. Angewandte Chemie 2014, 126 (7), 1980\u20131983. doi: 10.1002/anie.201308070", "ArticleIdList": ["10.1002/anie.201308070", "24449275"]}, {"Citation": "Wang J. C., Cellular roles of DNA topoisomerases: a molecular perspective. Nature reviews Molecular cell biology 2002, 3 (6), 430\u2013440. doi: 10.1038/nrm831", "ArticleIdList": ["10.1038/nrm831", "12042765"]}, {"Citation": "Liu L. F., DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem 1989, 58 (1), 351\u2013375.", "ArticleIdList": ["2549853"]}, {"Citation": "Shenkenberg T. D., Von Hoff D. D., Mitoxantrone: a new anticancer drug with significant clinical activity. Annals of internal medicine 1986, 105 (1), 67\u201381. doi: 10.7326/0003-4819-105-1-67", "ArticleIdList": ["10.7326/0003-4819-105-1-67", "3521429"]}, {"Citation": "Chilin A., Marzaro G., Marzano C., Dalla Via L., Ferlin M. G., Pastorini G., et al., Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity. Biorg. Med. Chem. 2009, 17 (2), 523\u2013529. doi: 10.1016/j.bmc.2008.11.072", "ArticleIdList": ["10.1016/j.bmc.2008.11.072", "19101158"]}, {"Citation": "Eissa I. H., Metwaly A. M., Belal A., Mehany A. B., Ayyad R. R., El\u2010Adl K., et al., Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Archiv der Pharmazie 2019, 352 (11), 1900123. doi: 10.1002/ardp.201900123", "ArticleIdList": ["10.1002/ardp.201900123", "31463953"]}, {"Citation": "Ibrahim M., Taghour M., Metwaly A., Belal A., Mehany A., Elhendawy M., et al., Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. European journal of medicinal chemistry 2018, 155, 117\u2013134. doi: 10.1016/j.ejmech.2018.06.004", "ArticleIdList": ["10.1016/j.ejmech.2018.06.004", "29885574"]}, {"Citation": "Abbass E. M., Khalil A. K., Mohamed M. M., Eissa I. H., El-Naggar A. M., Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Bioorganic chemistry 2020, 104, 104255. doi: 10.1016/j.bioorg.2020.104255", "ArticleIdList": ["10.1016/j.bioorg.2020.104255", "32927130"]}, {"Citation": "El-Helby A.-G. A., Sakr H., Ayyad R. R., Mahdy H. A., Khalifa M. M., et al.. Elhendawy, Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors. Bioorganic chemistry 2020, 103, 104233.", "ArticleIdList": ["32882440"]}, {"Citation": "Alesawy M. S., Al\u2010Karmalawy A. A., Elkaeed E. B., Alswah M., Belal A., Taghour M. S., et al., Design and discovery of new 1, 2, 4\u2010triazolo [4, 3\u2010c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Archiv Der Pharmazie 2021, 354 (3), 2000237. doi: 10.1002/ardp.202000237", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M. S., Eissa I. H., [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4\u2032, 3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorganic & Medicinal Chemistry 2021, 30, 115958.", "ArticleIdList": ["33360576"]}, {"Citation": "Shah P., Westwell A. D. J. J. o. e. i., m. chemistry, The role of fluorine in medicinal chemistry. 2007, 22 (5), 527\u2013540. doi: 10.1080/14756360701425014", "ArticleIdList": ["10.1080/14756360701425014", "18035820"]}, {"Citation": "Saoudi B., Teniou A., Debache A., Roisnel T., Soul\u00e9 J.-F., Doucet H., Cyclisation reaction between 3-methylquinoxaline-2-thione and benzaldehydes into 3-benzyl-2-aryl-thieno [2, 3-b] quinoxaline promoted by Br\u00f8nsted acids. Comptes Rendus Chimie 2015, 18 (8), 808\u2013815."}, {"Citation": "Morrison D., Furst A., Quinoxaline-2-thiols. The Journal of Organic Chemistry 1956, 21 (4), 470\u2013471."}, {"Citation": "Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods 1983, 65 (1\u20132), 55\u201363. doi: 10.1016/0022-1759(83)90303-4", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Denizot F., Lang R., Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of immunological methods 1986, 89 (2), 271\u2013277.", "ArticleIdList": ["3486233"]}, {"Citation": "Thabrew M., HUGHES R. D., MCFARLANE I. G., Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. Journal of pharmacy and pharmacology 1997, 49 (11), 1132\u20131135. doi: 10.1111/j.2042-7158.1997.tb06055.x", "ArticleIdList": ["10.1111/j.2042-7158.1997.tb06055.x", "9401951"]}, {"Citation": "Burres N. S., Frigo A., Rasmussen R. R., McAlpine J. B., A colorimetric microassay for the detection of agents that interact with DNA. Journal of natural products 1992, 55 (11), 1582\u20131587. doi: 10.1021/np50089a004", "ArticleIdList": ["10.1021/np50089a004", "1479377"]}, {"Citation": "Pommier Y., Topoisomerase II inhibitors: the epipodophyllotoxins, m-AMSA, and the ellipticine derivatives. Cancer chemotherapy and biotherapy: principles and practice 1996, 435\u2013461."}, {"Citation": "Meng L.-h., Zhang J.-s., Ding J., Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochemical pharmacology 2001, 62 (6), 733\u2013741. doi: 10.1016/s0006-2952(01)00732-8", "ArticleIdList": ["10.1016/s0006-2952(01)00732-8", "11551518"]}, {"Citation": "Bergant K., Janezic M., Perdih A., Bioassays and in silico methods in the identification of human DNA topoisomerase II\u03b1 inhibitors. Current Medicinal Chemistry 2018, 25 (28), 3286\u20133318.", "ArticleIdList": ["29508675"]}, {"Citation": "Atwal M., Swan R. L., Rowe C., Lee K. C., Lee D. C., Armstrong L., et al., Intercalating TOP2 poisons attenuate topoisomerase action at higher concentrations. Molecular Pharmacology 2019, 96 (4), 475\u2013484. doi: 10.1124/mol.119.117259", "ArticleIdList": ["10.1124/mol.119.117259", "PMC6744389", "31399497"]}, {"Citation": "Pucci B., Kasten M., Giordano A., Cell cycle and apoptosis. Neoplasia (New York, NY) 2000, 2 (4), 291. doi: 10.1038/sj.neo.7900101", "ArticleIdList": ["10.1038/sj.neo.7900101", "PMC1550296", "11005563"]}, {"Citation": "Eldehna W. M., Hassan G. S., Al-Rashood S. T., Al-Warhi T., Altyar A. E., Alkahtani H. M., et al., Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents. Journal of enzyme inhibition and medicinal chemistry 2019, 34 (1), 322\u2013332. doi: 10.1080/14756366.2018.1547286", "ArticleIdList": ["10.1080/14756366.2018.1547286", "PMC6366416", "30722708"]}, {"Citation": "Sabt A., Abdelhafez O. M., El-Haggar R. S., Madkour H. M., Eldehna W. M., El-Khrisy E. E.-D. A., et al., Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies. Journal of enzyme inhibition and medicinal chemistry 2018, 33 (1), 1095\u20131107. doi: 10.1080/14756366.2018.1477137", "ArticleIdList": ["10.1080/14756366.2018.1477137", "PMC6022226", "29944015"]}, {"Citation": "Al-Warhi T., Abo-Ashour M. F., Almahli H., Alotaibi O. J., Al-Sanea M. M., Al-Ansary G. H., et al., m. chemistry, Novel [(N-alkyl-3-indolylmethylene) hydrazono] oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and in silico studies. 2020, 35 (1), 1300\u20131309. doi: 10.1080/14756366.2020.1773814", "ArticleIdList": ["10.1080/14756366.2020.1773814", "PMC7717600", "32522063"]}, {"Citation": "Naowaratwattana W., De-Eknamkul W., De Mejia E. G., Phenolic-containing organic extracts of mulberry (Morus alba L.) leaves inhibit HepG2 hepatoma cells through G2/M phase arrest, induction of apoptosis, and inhibition of topoisomerase II\u03b1 activity. Journal of medicinal food 2010, 13 (5), 1045\u20131056.", "ArticleIdList": ["20828312"]}, {"Citation": "Li H., Xie N., Gleave M. E., Dong X. J. O., Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression. 2015, 6 (24), 20474.", "ArticleIdList": ["PMC4653019", "26009876"]}, {"Citation": "Wang L., Eastmond D. A. J. E., m. mutagenesis, Catalytic inhibitors of topoisomerase II are DNA\u2010damaging agents: induction of chromosomal damage by merbarone and ICRF\u2010187. 2002, 39 (4), 348\u2013356. doi: 10.1002/em.10072", "ArticleIdList": ["10.1002/em.10072", "12112387"]}, {"Citation": "Zhou H., Zhang Y., Fu Y., Chan L., Lee A. S. J. J. o. B. C., Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). 2011, 286 (29), 25687\u201325696.", "ArticleIdList": ["PMC3138298", "21622563"]}, {"Citation": "Ola M. S., Nawaz M., Ahsan H. J. M., c. biochemistry, Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. 2011, 351 (1), 41\u201358. doi: 10.1007/s11010-010-0709-x", "ArticleIdList": ["10.1007/s11010-010-0709-x", "21210296"]}, {"Citation": "Bhatt J. D., Chudasama C. J., Patel K. D. J. B., m. chemistry, Pyrazole clubbed triazolo [1, 5-a] pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study. 2015, 23 (24), 7711\u20137716. doi: 10.1016/j.bmc.2015.11.018", "ArticleIdList": ["10.1016/j.bmc.2015.11.018", "26631439"]}, {"Citation": "Alanazi M. M., Elkady H., Alsaif N. A., Obaidullah A. J., Alanazi W. A., Al-Hossaini A. M., et al., Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study. 2022, 1253, 132220."}, {"Citation": "Kumar A., Bora U., Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes. Interdisciplinary Sciences: Computational Life Sciences 2014, 6 (4), 285\u2013291. doi: 10.1007/s12539-012-0048-6", "ArticleIdList": ["10.1007/s12539-012-0048-6", "25118649"]}, {"Citation": "Venkatapathy R., Wang N. C. Y., Martin T. M., Harten P. F., Young D., Structure\u2013Activity Relationships for Carcinogenic Potential. General, Applied and Systems Toxicology 2009."}, {"Citation": "Goodrnan G., Wilson R., Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Analysis 1992, 12 (4), 525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "N. R. Council, Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment. In Issues in Risk Assessment, National Academies Press (US): 1993."}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E., Comparison of in silico tools for evaluating rat oral acute toxicity. SAR and QSAR in Environmental Research 2015, 26 (1), 1\u201327. doi: 10.1080/1062936X.2014.977819", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Louisse J., Bosgra S., Blaauboer B. J., Rietjens I. M., Verwei M., Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling. Archives of toxicology 2015, 89 (7), 1135\u20131148. doi: 10.1007/s00204-014-1289-4", "ArticleIdList": ["10.1007/s00204-014-1289-4", "24935252"]}, {"Citation": "EPA Guidelines for Developmental Toxicity Risk Assessment. https://www.epa.gov/sites/production/files/2014-11/documents/dev_tox.pdf (accessed May 2020)."}, {"Citation": "Pizzo F., Benfenati E., In silico models for repeated-dose toxicity (RDT): prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs. In In Silico Methods for Predicting Drug Toxicity, Springer: 2016; pp 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C. J., Bruce R. M., Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. Journal of chemical information and computer sciences 2004, 44 (5), 1623\u20131629. doi: 10.1021/ci049903s", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}, {"Citation": "Wilhelmus K. R., The Draize eye test. Survey of ophthalmology 2001, 45 (6), 493\u2013515. doi: 10.1016/s0039-6257(01)00211-9", "ArticleIdList": ["10.1016/s0039-6257(01)00211-9", "11425356"]}, {"Citation": "El\u2010Kerdawy M. M., Ismaiel A. E. K. M., Gineinah M. M., Glennon R. A. J. J. o. h. c., A convenient synthesis of 3\u2010aryl\u20101, 2, 4\u2010triazolo [4, 3\u2010c] quinazolines. 1990, 27 (3), 497\u2013501."}, {"Citation": "Al-Rashood S. T., Hamed A. R., Hassan G. S., Alkahtani H. M., Almehizia A. A., Alharbi A., Al-Sanea M. M., Eldehna W. M., Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35 (1), 831\u2013839. doi: 10.1080/14756366.2020.1743281", "ArticleIdList": ["10.1080/14756366.2020.1743281", "PMC7144320", "32208781"]}, {"Citation": "Ibrahim M.-K., Abd-Elrahman A. A., Ayyad R. R., El-Adl K., Mansour A. M., Eissa I. H., Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1 (2H)-yl)-N-(4-(substituted) phenyl) acetamide derivatives for biological evaluation as anticonvulsant agents. Bulletin of Faculty of Pharmacy, Cairo University 2013, 51 (1), 101\u2013111."}, {"Citation": "Zhou D.-C., Lu Y.-T., Mai Y.-W., Zhang C., Xia J., Yao P.-F., et al., Design, synthesis and biological evaluation of novel perimidine o-quinone derivatives as non-intercalative topoisomerase II catalytic inhibitors. Bioorganic chemistry 2019, 91, 103131. doi: 10.1016/j.bioorg.2019.103131", "ArticleIdList": ["10.1016/j.bioorg.2019.103131", "31377387"]}, {"Citation": "Eldehna W. M., Al-Rashood S. T., Al-Warhi T., Eskandrani R. O., Alharbi A., El Kerdawy A. M. J. J. o. e. i., m. chemistry, Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3\u03b2 inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies. 2021, 36 (1), 270\u2013285.", "ArticleIdList": ["PMC7751407", "33327806"]}, {"Citation": "Sabt A., Eldehna W. M., Al-Warhi T., Alotaibi O. J., Elaasser M. M., Suliman H., et al., m. chemistry, Discovery of 3, 6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights. 2020, 35 (1), 1616\u20131630.", "ArticleIdList": ["PMC7470104", "32781872"]}, {"Citation": "Lo K. K.-W., Lee T. K.-M., Lau J. S.-Y., Poon W.-L., Cheng S.-H., Luminescent biological probes derived from ruthenium (II) estradiol polypyridine complexes. Inorganic chemistry 2008, 47 (1), 200\u2013208. doi: 10.1021/ic701735q", "ArticleIdList": ["10.1021/ic701735q", "18067284"]}, {"Citation": "Balah A., Ezzat O., Akool E.-S., Vitamin E inhibits cyclosporin A-induced CTGF and TIMP-1 expression by repressing ROS-mediated activation of TGF-\u03b2/Smad signaling pathway in rat liver. International immunopharmacology 2018, 65, 493\u2013502.", "ArticleIdList": ["30391882"]}, {"Citation": "Aborehab N. M., Elnagar M. R., Waly N. E., Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF\u20107 human breast cancer cell line. Journal of Biochemical and Molecular Toxicology 2020, e22638. doi: 10.1002/jbt.22638", "ArticleIdList": ["10.1002/jbt.22638", "33002289"]}, {"Citation": "Elnagar M. R., Walls A. B., Helal G. K., Hamada F. M., Thomsen M. S., Jensen A. A., Functional characterization of \u03b17 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay. European journal of pharmacology 2018, 826, 106\u2013113.", "ArticleIdList": ["29501870"]}, {"Citation": "El-Helby A. G. A., Ayyad R. R., Sakr H. M., Abdelrahim A. S., El-Adl K., Sherbiny F. S., et al., Design, synthesis, molecular modeling and biological evaluation of novel 2, 3-dihydrophthalazine-1, 4-dione derivatives as potential anticonvulsant agents. Journal of Molecular Structure 2017, 1130, 333\u2013351."}, {"Citation": "Ibrahim M. K., Eissa I. H., Alesawy M. S., Metwaly A. M., Radwan M. M., ElSohly M. A., Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Biorg. Med. Chem. 2017, 25 (17), 4723\u20134744.", "ArticleIdList": ["28720328"]}, {"Citation": "El-Gamal K. M., El-Morsy A. M., Saad A. M., Eissa I. H., Alswah M., Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J. Mol. Struct. 2018, 1166, 15\u201333."}, {"Citation": "Youssef M. I., Zhou Y., Eissa I. H., Wang Y., Zhang J., Jiang L., et al., Tetradecyl 2, 3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochemistry International 2020, 104749. doi: 10.1016/j.neuint.2020.104749", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "El-Naggar A. M., Eissa I. H., Belal A., El-Sayed A. A. J. R. A., Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site. 2020, 10 (5), 2791\u20132811.", "ArticleIdList": ["PMC9048505", "35496078"]}, {"Citation": "Alanazi M. M., Elkady H., Alsaif N. A., Obaidullah A. J., Alkahtani H. M., Alanazi M. M., et al., New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. 2021, 11 (48), 30315\u201330328.", "ArticleIdList": ["PMC9044819", "35493991"]}, {"Citation": "Brooks B. R., Brooks C. L. III, Mackerell A. D. Jr, Nilsson L., Petrella R. J., Roux B., et al., CHARMM: the biomolecular simulation program. 2009, 30 (10), 1545\u20131614.", "ArticleIdList": ["PMC2810661", "19444816"]}, {"Citation": "Jo S., Cheng X., Islam S. M., Huang L., Rui H., Zhu A., et al., s. biology, CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. 2014, 96, 235\u2013265. doi: 10.1016/bs.apcsb.2014.06.002", "ArticleIdList": ["10.1016/bs.apcsb.2014.06.002", "PMC4739825", "25443960"]}, {"Citation": "Jo S., Kim T., Iyer V. G., W. J. J. o. c. c. Im, CHARMM\u2010GUI: a web\u2010based graphical user interface for CHARMM. 2008, 29 (11), 1859\u20131865.", "ArticleIdList": ["18351591"]}, {"Citation": "Lee J., Cheng X., Swails J. M., Yeom M. S., Eastman P. K., Lemkul J. A., et al., computation, CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. 2016, 12 (1), 405\u2013413. doi: 10.1021/acs.jctc.5b00935", "ArticleIdList": ["10.1021/acs.jctc.5b00935", "PMC4712441", "26631602"]}, {"Citation": "Abraham M. J., Murtola T., Schulz R., P\u00e1ll S., Smith J. C., Hess B., Lindahl E. J. S., GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. 2015, 1, 19\u201325."}, {"Citation": "Ekberg V., Ryde U. J. J. o. c. t., computation, On the use of interaction entropy and related methods to estimate binding entropies. 2021, 17 (8), 5379\u20135391. doi: 10.1021/acs.jctc.1c00374", "ArticleIdList": ["10.1021/acs.jctc.1c00374", "PMC8389774", "34254810"]}, {"Citation": "Vald\u00e9s-Tresanco M. S., Vald\u00e9s-Tresanco M. E., Valiente P. A., Moreno E. J. J. o. C. T., Computation, gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. 2021, 17 (10), 6281\u20136291. doi: 10.1021/acs.jctc.1c00645", "ArticleIdList": ["10.1021/acs.jctc.1c00645", "34586825"]}, {"Citation": "Miller B. R. III, McGee T. D. Jr, Swails J. M., Homeyer N., Gohlke H., Roitberg A. E. J. J. o. c. t., computation, MMPBSA. py: an efficient program for end-state free energy calculations. 2012, 8 (9), 3314\u20133321.", "ArticleIdList": ["26605738"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "11"}, {"Year": "2022", "Month": "8", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "30", "Hour": "14", "Minute": "43"}, {"Year": "2023", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36716311", "PMC9886266", "10.1371/journal.pone.0274081", "PONE-D-22-16827"]}}], "PubmedBookArticle": []}